Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 19Unknown 3Terminated 2Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 8Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 1328Neoplasms 998Carcinoma, Non-Small-Cell Lung 865Prostatic Neoplasms 730Colorectal Neoplasms 671Lung Neoplasms 553Leukemia, Myeloid, Acute 475Neoplasm Metastasis 427Pancreatic Neoplasms 426Carcinoma, Hepatocellular 407Ovarian Neoplasms 393Multiple Myeloma 393Stomach Neoplasms 383Recurrence 369Squamous Cell Carcinoma of Head and Neck 327Melanoma 295Uterine Cervical Neoplasms 288Brain Neoplasms 288Triple Negative Breast Neoplasms 273Glioblastoma 263Head and Neck Neoplasms 260Precursor Cell Lymphoblastic Leukemia-Lymphoma 256Endometrial Neoplasms 238Lymphoma 230Esophageal Neoplasms 226Rectal Neoplasms 224Sarcoma 213Carcinoma, Renal Cell 205Colonic Neoplasms 196Lymphoma, Large B-Cell, Diffuse 194

Interventions

Nutrition Assessment 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Interventional × Heart Diseases × Clear all
NCT07126587 2025-10-30

HLA

University of North Carolina, Chapel Hill

Phase NA Recruiting
120 enrolled
Other

Diabetes Mellitus, Type 2, Heart Diseases, Hypercholesterolemia, Hypertension, Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡